Delivery Order SPE2DB22D2214-SPE2DB24FS5VE

Award Date 7/16/24
Potential Completion Date 8/6/24
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $11,468.49, is for the delivery of the drug MEKINIST 2 MG TABLET in 30-tablet units. This is a firm fixed-price delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, which has a ceiling value of up to $999,999,999 and runs through December 2025. The contract does...
This federal contract award, valued at $4,042.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of MEKINIST 0.05 MG/ML SOLUTION 90ML, a pharmaceutical product, with an ultimate completion date of October 31, 2024. This is a firm fixed-price delivery order contract, and there was no set-aside designation used. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,878.79 firm fixed-price delivery order is for the drug MEKINIST 2 MG TABLET, with a completion date of July 16, 2024. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,589.70 for the provision of MEKINIST 0.5 MG TABLET medical products. The award was made on June 6, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 28, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of medical supplies, including the drug MEKINIST 2MG TAB 30S. The contract has a firm fixed price of $18,371.32 and runs through January 27, 2025. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award is for the delivery of MEKINIST 0.5 MG TABLET UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $2,589.70, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 12, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,670.51 firm fixed-price delivery order is for the supply of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The contract has an ultimate completion date of February 19, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,318.41, is for the delivery of MEKINIST 2 MG TABLET UU 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 7, 2025. The award does not have a set-aside designation, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $19,341.02, is a delivery order for the supply of 4567490486 MEKINIST 2 MG TABLET UU 30S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The $18,371.32 fixed-price award is for the delivery of 4,566,462,969 units of the drug MEKINIST 2 MG Tablet with a completion date of December 10, 2024. The contract has no set-aside designation, indicating open competition. AmerisourceBergen is the prime contractor, and the award is...
  • SPE2DB22D2214
    Indefinite Delivery Contract
  • SPE2DB22D2214-SPE2DB24FS5VE
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation (Amerisourcebergen), a major pharmaceutical distributor, for the delivery of MEKINIST 0.5 MG TABLET. The contract has a ceiling value of $2,589.70 and an ultimate completion date of August 6, 2024. It is a firm-fixed-price delivery order contract with no set-aside designation.

Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to supply a wide range of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies. The company holds several Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued at up to $999,999,999 and $750,000 respectively, which serve as primary vehicles for providing these essential medical commodities to various federal healthcare programs and facilities.

Generated 10/15/24, 9:38 PM